Baricitinib plus steroids for polymyalgia rheumatica
Treatments studied
Part of Bones, joints & muscles, Skin clinical trials.
This trial tests if adding baricitinib (a pill that calms inflammation) to standard steroids works better than steroids alone for people with polymyalgia rheumatica. It aims to improve symptoms and reduce steroid side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 50 or older
- Diagnosed with polymyalgia rheumatica (either new or not improving with treatment)
- Not taking steroids, or taking less than 15 mg of prednisone per day for at least 2 weeks before starting
- Active disease (PMR-AS-CRP score greater than 17)
- No other inflammatory joint disease, connective tissue disease, or blood vessel inflammation
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if new imaging methods can help diagnose and treat polymyalgia rheumatica (PMR). It may be for you if you're over 50, have pain in your shoulders or hips, and haven't taken steroids for PMR in the last 2 months.
This study tests whether a daily pill (tofacitinib) combined with a short course of steroids can help people with active PMR use less steroids over time. You must have high disease activity and not have taken steroids or biologics in the past two weeks.
This trial studies whether baricitinib can improve symptoms and test results in adults with active dermatomyositis (a muscle and skin inflammation disease). It’s for people whose disease is still active despite prior treatment or who have been recently diagnosed.
This trial tests a new daily pill, ivarmacitinib, for people with polymyalgia rheumatica (PMR). It may help control symptoms without needing steroids long-term.
This study tests if baricitinib, an anti-inflammatory pill, can help people with arthritis caused by CPPD crystals (also called pseudogout). It is for people aged 55 and older who have swelling in their hands/wrists or large joints.
This trial tests if baricitinib, a medication for rheumatoid arthritis, can improve blood clotting issues that some patients with active RA face. It is for adults whose RA is not well-controlled by standard treatments.
Hear when a new Polymyalgia Rheumatica (PMR) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.